Dr Sanil Rege

March 26, 2018

Time to read: 10–12 minutes

In early February 2018, the Australian government published their health spending figures for 2015/2016, which showed that $9 billion was spent on menta...

 Dr Sanil Rege

March 26, 2018

Time to read: 5 minutes

The recent Cipriani et al. systematic review and network meta-analysis is the largest and most comprehensive examination of antidepressant efficacy and ...

 Dr Sanil Rege

March 23, 2018

Time to read: 10 minutes

Antidepressants are widely used treatments for major depressive disorder. However, there is considerable debate on their effectiveness because their sho...

 Prof Paul Fitzgerald, Dr Ted Cassidy

February 19, 2018

Time to read: 4 minutes

Mr OB is a 31-year-old man who is a qualified teacher and semi-professional Actor. He has never worked full time as a teacher due to his chronic depress...

 Prof Paul Fitzgerald, Dr Ted Cassidy, Dr Sanil Rege

January 29, 2018

Time to read: 9 minutes

Major depressive disorder (MDD) is a chronic and debilitating form of mental illness that is characterised by behavioural, affective, cognitive and soma...

 Dr Sanil Rege, Dr James Graham

January 28, 2018

Time to read: 4 minutes

Cardiovascular disease (CVD) is a leading cause of premature death and is traditionally linked to five disease risk factors: 1) Obesity...

 Dr Sanil Rege, Dr James Graham

November 28, 2017

Time to read: 4 minutes

Depression has a lower prevalence in men than in women although this lower incidence may be due to the gender biases in seeking help. ...

 Dr Sanil Rege, Dr James Graham

October 30, 2017

Time to read: 10 minutes

Fibromyalgia is a chronic pain syndrome that is characterised by widespread pain, joint stiffness and multiple tender points around the body. There is a...

 Dr Sanil Rege, Dr James Graham

October 27, 2017

Time to read: 5 minutes

Vortioxetine is an atypical antidepressant with multimodal activity. It is a serotonin modulator and stimulator because although it has SERT inhibition ...

 Dr Sanil Rege, Dr James Graham

October 27, 2017

Time to read: 6 minutes

Agomelatine is a novel and atypical antidepressant that acts as a melatonergic antidepressant and has a distinctly favourable side effect profile....